Press "Enter" to skip to content

GSK and Novartis liniment marketing misled Australian consumers: court

The Australian subsidiaries of British drugmaker GlaxoSmithKline and Swiss drugmaker Novartis misled customers and broke the law by promoting identical liniments as though they could treat specific ills, an Australian court found on Friday.

Original source:

Also Read:   "Pay-for-delay" deals over drug generics unlawful: EU court adviser